In contrast, MAP2K1 is broadly expressed across cholangiocyte lineages but is most enriched in the malignant and highly proliferative subsets (log2FC: 25.16, padj = 8.29 × 10−139), aligning with MAPK pathway activation in tumor cells. This evidence concerns the gene MAP2K1 and neoplasm.